EFFICACY AND SAFETY OF NEMTABRUTINIB VERSUS CHEMOIMMUNOTHERAPY IN PATIENTS WITH PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA WITHOUT TUMOR PROTEIN 53 ABERRATIONS: THE OPEN-LABEL, RANDOMIZED, PHASE 3 BELLWAVE-008 STUDY
a Hospital Paulistano, São Paulo, Brazil
b Medical University of Lublin, Lublin, Poland
c National Taiwan University Hospital, Taipei City, Taiwan
d Markhot Ferenc Teaching Hospital Eger, Eger, Hungary
e Merck & Co., Inc., Rahway, United States
f ACT Pretoria East Haematology Centre, Pretoria, South Africa
Lido
1102
Vezesque se leu este artigo
441
Total PDF
661
Total HTML
| Ano/Mês | Html | Total | |
|---|---|---|---|
| 2025 6 | 34 | 16 | 50 |
| 2025 5 | 78 | 16 | 94 |
| 2025 4 | 51 | 15 | 66 |
| 2025 3 | 65 | 6 | 71 |
| 2025 2 | 52 | 30 | 82 |
| 2025 1 | 40 | 28 | 68 |
| 2024 12 | 34 | 29 | 63 |
| 2024 11 | 28 | 17 | 45 |
| 2024 10 | 12 | 17 | 29 |
| 2024 9 | 25 | 23 | 48 |
| 2024 8 | 22 | 28 | 50 |
| 2024 7 | 23 | 29 | 52 |
| 2024 6 | 27 | 26 | 53 |
| 2024 5 | 25 | 29 | 54 |
| 2024 4 | 31 | 26 | 57 |
| 2024 3 | 35 | 22 | 57 |
| 2024 2 | 22 | 15 | 37 |
| 2024 1 | 5 | 18 | 23 |
| 2023 12 | 15 | 22 | 37 |
| 2023 11 | 25 | 19 | 44 |
| 2023 10 | 12 | 10 | 22 |
Mostrar tudo
